The role of patient-specific variables in protein corona formation and therapeutic efficacy in nanomedicine

Abstract Despite their potential, the adoption of nanotechnology in therapeutics remains limited, with only around eighty nanomedicines approved in the past 30 years. This disparity is partly due to the “one-size-fits-all” approach in medical design, which often overlooks patient-specific variables...

Full description

Saved in:
Bibliographic Details
Main Authors: Ethan P. Cisneros, Brinkley A. Morse, Ani Savk, Khyati Malik, Nicholas A. Peppas, Olivia L. Lanier
Format: Article
Language:English
Published: BMC 2024-11-01
Series:Journal of Nanobiotechnology
Subjects:
Online Access:https://doi.org/10.1186/s12951-024-02954-y
Tags: Add Tag
No Tags, Be the first to tag this record!